Core Insights - Fagron, a leading global player in pharmaceutical compounding, has published its Annual Report for the financial year 2025, following the announcement of its annual financial results on February 12, 2026 [1][2]. Group 1: Annual Report Details - The Annual Report is available on Fagron's website in both Dutch and English, including a sustainability report for the financial year 2025 [2]. - The Annual Report will be presented at the Annual General Meeting of Shareholders scheduled for May 11, 2026 [2]. Group 2: Financial Calendar - Key dates in Fagron's financial calendar include: - April 9, 2026: Trading update for the first quarter of 2026 - May 11, 2026: Annual General Meeting for 2026 - July 30, 2026: Half-year results for 2026 - October 8, 2026: Trading update for the third quarter of 2026 - Results and trading updates are published at 7:00 AM CET [3]. Group 3: Company Overview - Fagron is based in Nazareth, Belgium, and is listed on Euronext Brussels and Euronext Amsterdam under the ticker symbol 'FAGR' [5]. - The operational activities of Fagron are managed through Fagron BV, which has its head office in Rotterdam, Netherlands [5]. - Fagron focuses on delivering personalized medicine to hospitals, pharmacies, clinics, and patients in over 38 countries worldwide [4].
Fagron publishes its Annual Report 2025
Globenewswire·2026-03-06 06:00